cGxP.wire https://validator.w3.org/feed/docs/rss2.html Velico Reports Positive Trial Results for FrontlineODP Kyowa Hakko Presents New Evidence Supporting Cognizin’s Cognitive Benefits Avance Clinical Highlights Oncology Expertise at ASCO 2026 Belay Announces NCCN Recommendation for CSF-Based Profiling in High-Grade Gliomas Novocure Reports Phase 3 TRIDENT Trial Results CareDx Publishes New KOAR Kidney Transplant Data iQure Pharma Wins MJFF Grant for Parkinson’s Research cAMPfield Launches With $180M to Advance Oral IBD Therapy PleoPharma Launches Phase 3 Trial for Cannabis Withdrawal CareDx Highlights Transplant Data at ATC 2026 Cambrian Bio Reports Positive Phase 1b ATX-304 Data New Gates Foundation Grant Fuels Replicate’s Fight Against Tuberculosis Takeda Deploys Boltz AI Models to Accelerate Drug Discovery Voro and Alloy Partner on Next-Gen T-Cell Cancer Therapies Incyte Secures Japan Approval for Minjuvi in DLBCL Care Kither Biotech Completes Phase 1 Trial of KIT2014 NIH Study Reveals Brain Cells Driving Human Speech Activity Sanofi Wins Japan Approval for Sarclisa SC in Myeloma uniQure Reports Early AMT-260 Epilepsy Trial Results NYU Langone Performs First HIV-to-HIV Lung Transplant Telos Biotech and Made Scientific Partner to Advance TELOVANCE™ Evaluation Alexion’s Ultomiris Gets FDA Priority Review for IgAN Moderna Gains FDA Panel Support for mRNA-1010 Flu Vaccine Teva Highlights Long-Term AUSTEDO Success in Tardive Dyskinesia Care Diazyme Laboratories Secures FDA Clearance for Lp(a) Assay TrialAssure and Cancer Research UK Partner on AI Regulatory Authoring Denali Therapeutics to Sell FDA Priority Review Voucher for $195M Merck’s CAPVAXIVE Wins FDA Approval for High-Risk Children Allarity Therapeutics Showcases Phase 2 Stenoparib Trial Design at ESMO 2026 Curium Court Victory Clears Path for U.S. GEP-NET Therapy Prime Medicine Receives New Zealand CTA Clearance for PM577a in Wilson Disease SK pharmteco Partners With OTXL to Advance Rare Therapies Genentech FDA Filing Advances Lunsumio-Polivy in LBCL FDA Approves First Generic Xofluza for Influenza Treatment Mabwell Showcases Strong 9MW2821 Cervical Cancer Data AVITA Medical Reports First U.K. Clinical Success with RECELL GO GSK and Spero Secure FDA Nod for First Oral Carbapenem GRI Bio Secures FDA Orphan Drug Designation for GRI-0621 in IPF MAIA Biotechnology Expands THIO-101 Trial with Winship Enrollment Biogen Signs Landmark RayThera Acquisition Worth Up to $1 Billion Longeveron Reports New Phase 2a Laromestrocel Alzheimer’s Data LabGenius and LG Chem Partner on AI-Designed Cancer Antibodies AIM ImmunoTech Completes Phase 2 DURIPANC Enrollment Cadrenal Therapeutics to Seek FDA Rare Pediatric Designation Samsung Bioepis and Organon Expand PYZCHIVA Rights in Canada Boehringer Ingelheim Reports Survival Gains With Nerandomilast LIR Shows Successful Needle-Free Delivery of GLP-1 Therapies Lupin Launches Azilsartan Medoxomil Tablets in U.S. Market TORL BioTherapeutics Reports Promising Ovarian Cancer Data Insilico Medicine Reports First Human Dosing of ISM8969